Interstitial Lung Disease (ILD)/Pneumonitis occurred in 3.5% and was fatal in 0.6% of 833 TAGRISSO-treated patients.
Interstitial Lungenerkrankung (ILD) / Pneumonitis ass am 3.3% a fatal an 0.5% vun 813 TAGRISSO Patienten.